The overexpression of TM4SF5 in tumor cells makes it an attractive target for cancer therapeutics, as it can serve as a molecular marker for the selective delivery of treatment to cancer cells while minimizing off-target effects on healthy cells [9]. The gene discussed is TM4SF5; the disease is cancer.